Moderna pens deal with China to make mRNA medicines that ‘will not be exported’

Moderna signed a deal Wednesday to develop and manufacture mRNA medicines in China, after other US and European Covid-19 drugmakers struggled to break into the market without a Chinese partner.

Under the agreement, the Cambridge, MA vaccine developer will produce medicines in China that “will be exclusively for the Chinese people” and “will not be exported,” according to an emailed statement from Moderna.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

Rep. Raul Ruiz on going from the emergency room to Congress

Before he joined Congress, Rep. Raul Ruiz, a Democrat from California, worked in another chaotic environment: the emergency department. Today, he says, he tries to

December 6, 2023

New insights into coronavirus E channel could lead to antiviral drugs

The genome of the SARS-CoV-2 virus encodes 29 proteins, one of which is an ion channel called E. This channel, which transports protons and calcium

October 14, 2023

Single Monoclonal Antibody Injection Protected Kids Against Malaria

A single subcutaneous injection of an investigational monoclonal antibody was safe and effective in preventing malaria in children in Mali, according to results of the

April 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.